Featured Research

from universities, journals, and other organizations

A New Player In The Battle Against Hepatitis Prevents Inflammation And The Death Of Liver Cells

Date:
September 5, 2005
Source:
VIB, Flanders Interuniversity Institute of Biotechnology
Summary:
Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) have again achieved a breakthrough in research on hepatitis. The researchers, connected to Ghent University, have discovered the function of one of the most important proteins involved in hepatitis. Using a mouse model, they have shown that the protein prevents inflammation of the liver as well as the death of liver cells. This discovery can form the basis for the development of a new therapy in the battle against hepatitis in humans.

Related Articles


Hepatitis, a liver disorder

Hepatitisis a collective term for a number of inflammations of the liver whosesymptoms strongly resemble each other. These inflammations can have awide variety of causes, such as alcohol abuse or infection by ahepatitis virus. Hepatitis B and C, for example, are caused by a virusthrough contact with the blood or other bodily fluids of infectedpersons. In some cases, the person remains a carrier of the virus, andchronic hepatitis and even cancer of the liver can develop.

InBelgium, at least 700,000 people have had hepatitis B, and 5%-10% ofthese persons are still chronic carriers of the virus. Each year, thereare about 6000 new infections. The number of people with hepatitis Ccomes to 80,000-100,000 - and 60%-80% of these persons develop chronichepatitis. There is a vaccination against hepatitis B, but none againsthepatitis C.

A new role for the protein ABIN-1

TNF(Tumor Necrosis Factor) is produced by our body, normally in smallquantities. In inflammations of the liver, excessive TNF productionactivates the mechanisms that lead to inflammation and the death ofliver cells and liver tissue. In addition, excessive TNF in liver cellsstimulates the protein NF-ƒkB, which is also responsible for theinflammation of the liver. This makes NF-ƒkB an attractive target for atherapy that would neutralize the inflammation. However, an idealtherapy also needs to prevent the death of the liver cells.

Thenew player that this research brings a step closer to the realizationof such a therapy is the protein ABIN-1. From previous research by theVIB research group - led by Rudi Beyaert - it turns out that ABIN-1inhibits the action of NF-ƒkB. Now, Andy Wullaert and severalcolleagues from this team have shown that an extra dose of ABIN-1provides a double protection to liver cells in mice. With an elevatedproduction of ABIN-1, this protein will neutralize the inflammationcaused by NF-ƒkB and also prevent the complete death of liver cellsafter induction by TNF.

ABIN-1 in the treatment of liver disorders

Thisresearch discloses the double protective action of ABIN-1 in liverdisorders. NF-ƒkB, also responsible for inflammations, is inhibited byan elevated presence of ABIN-1. In addition, ABIN-1 also counteractsthe death of liver cells. Further research can lead to new therapies inthe battle against hepatitis, through which - by increasing thepresence of ABIN-1 in the liver - one can inhibit the inflammation andprevent dell death.


Story Source:

The above story is based on materials provided by VIB, Flanders Interuniversity Institute of Biotechnology. Note: Materials may be edited for content and length.


Cite This Page:

VIB, Flanders Interuniversity Institute of Biotechnology. "A New Player In The Battle Against Hepatitis Prevents Inflammation And The Death Of Liver Cells." ScienceDaily. ScienceDaily, 5 September 2005. <www.sciencedaily.com/releases/2005/09/050904230438.htm>.
VIB, Flanders Interuniversity Institute of Biotechnology. (2005, September 5). A New Player In The Battle Against Hepatitis Prevents Inflammation And The Death Of Liver Cells. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2005/09/050904230438.htm
VIB, Flanders Interuniversity Institute of Biotechnology. "A New Player In The Battle Against Hepatitis Prevents Inflammation And The Death Of Liver Cells." ScienceDaily. www.sciencedaily.com/releases/2005/09/050904230438.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Breakfast Debate: To Eat Or Not To Eat?

Breakfast Debate: To Eat Or Not To Eat?

Newsy (Oct. 23, 2014) Conflicting studies published in the same week re-ignited the debate over whether we should be eating breakfast. Video provided by Newsy
Powered by NewsLook.com
Ebola Fears Keep Guinea Hospitals Empty

Ebola Fears Keep Guinea Hospitals Empty

AP (Oct. 23, 2014) Fears of Ebola are keeping doctors and patients alike away from hospitals in the West African nation of Guinea. (Oct. 23) Video provided by AP
Powered by NewsLook.com
Despite Rising Death Toll, Many Survive Ebola

Despite Rising Death Toll, Many Survive Ebola

AP (Oct. 23, 2014) The family of a Dallas nurse infected with Ebola in the US says doctors can no longer detect the virus in her. Despite the mounting death toll in West Africa, there are survivors there too. (Oct. 23) Video provided by AP
Powered by NewsLook.com
Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins